Advanced Filters
noise

covid-19 Clinical Trials

A listing of covid-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 347 clinical trials
T Tahir Kafil, MD

COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry

Myocarditis and pericarditis are inflammatory diseases of the myocardium and pericardium, and can be related to different causes, including vaccines. In the past, some people developed inflammatory heart disease after receiving a live or inactive virus vaccine (smallpox vaccine or flu vaccine). Myocarditis was also seen in people with COVID-19. …

5 years of age All Phase N/A
E Ema Perez, BS

Effect of Apollo Wearable on Long COVID-19 Symptoms.

The purpose of this study is to examine how Apollo wearable use impacts symptoms and quality of life following long COVID.

18 years of age All Phase N/A
Y Yuhan Liu

Presynaptic Imaging in Major Depressive Episodes After COVID-19

The goal of this observational study focuses on understanding and addressing a subset of persistent neuropsychiatric symptoms occurring within 3 months after mild to moderate COVID-19 infection (COVID-DNP). COVID-DNP encompasses major depressive episodes (MDE) with or without additional neuropsychiatric symptoms.

18 - 75 years of age All Phase N/A
L Lin Bingliang, MD

Evaluation of COVID-19 Immune Barrier and Reinfection Risk

The goal of this observational study is to evaluate the protective effect of immune barrier on secondary infection after COVID-19 (coronavirus disease 2019) vaccination or COVID-19 virus Omicron B A. 5.2 strain infection by dynamically monitoring the COVID-19 antibody titer, cellular immune function and the occurrence of secondary infection of …

years of age All Phase N/A
E Emilie N Eilersen, MD

Carotid Stenosis Management During COVID-19 Era - Pilot Study

Carotid endarterectomy (CEA) and carotid stenting (CAS) are often performed for subgroups of patients for whom procedural benefit has not been established in randomised trials and despite evidence of serious procedural risk. In some places, the COVID-19 pandemic has made it difficult or impossible to perform CEA and CAS in …

45 years of age All Phase N/A
J Jingyyuan Xu, MD

Prognostic Value of PtcO2 in Patients With COVID-19

Five percent of patients with COVID-19 progressed to respiratory failure and required ICU admission, such patients often have abnormal oxygen tolerance. However, there is still a lack of clinical indicators to predict the prognosis and treatment responsiveness of COVID-19.

18 - 80 years of age All Phase N/A
R Rukshana Hossain, MPH

The Nanowear Wearable Covid-19 Observational and Analysis Trend

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

18 years of age All Phase N/A
L Luisa Verga, MD

S Protein and COVID-19: a Monocentric Prospective Study

The aim of this study is to compare plasma S Protein levels to SARS-CoV-2 viral load in COVID positive patients.

18 years of age All Phase N/A
L Luis TEIXEIRA

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

In the context of malignant disease, it is likely that vaccine efficacy and immunogenicity depends on the type of pathology, stage of the disease, immunosuppression induced by the treatments, in addition to more classic factors such as age, general condition and possibly the type of vaccine used. There are very …

18 years of age All Phase N/A
C Claudia Spies, MD, Prof.

Post-intensive Care Syndromes in Pregnant Patients With Respiratory Failure and COVID-19 Compared to Non-pregnant Patients With Respiratory Failure and COVID-19

The aim of this study is to characterize patients in the Post-Intensive-Care-Syndrome (PICS) outpatient clinic based on routine data and to evaluate their treatment outcome over the course of their treatment. For this purpose, data sets from approx. 40 patients who were treated in the intensive care unit subsequently evaluated …

18 years of age All Phase N/A

Simplify language using AI